Types | Methods | Testing instruments | Main findings | Clinical recommendation |
---|---|---|---|---|
Questionnaires and structured interviews | Questionnaires delivered during interviews | • PD drivers reported a high incident of collisions [12, 53, 62]. Patients with higher disease severity reported more collisions. • Up to 21 % of PD drivers gave up driving soon after diagnosis was made [12, 53] • Falling asleep while driving was a significant pre had found in PD drivers, and usually related with dopamine agonist medications [54, 55, 58] | • Appropriate as a screening instrument for physicians in routine clinical practice | |
• Excessive daytime somnolence (EDS) and sleep attacks are more common in PD drivers than controls [40, 60, 61]. • EDS is associated with dopamine agonist medications [56] • PD drivers scored worse on ESS score than controls [60, 61] • Falling asleep while driving a car was a significant prognostic factor of car accidents [24, 59] | • ESS is a useful screening instrument for EDS and sleep attacks in PD patients. This test should be performed in PD drivers with history of daytime somnolence. | |||
2. Off-road testing battery | Motor assessment | Hoehn & Yahr [3, 4, 13, 14, 19–21, 25, 37, 64, 70–75, 77–79, 81, 91] | • Greater HY score correlated with higher number of collisions or driving errors [37] • Greater HY score correlated with poor driving performance and a failed result with on-road tests [21, 25, 75, 77] | • HY scale should be part of the clinical evaluation in PD patients who come for fitness to drive assessment. |
UPRDS-motor [13, 14, 19, 20, 23, 25, 37, 64–67, 69–71, 73–80, 82, 91] | • High UPDRS-motor score correlated with greater of collision [37] • High UPDRS-motor score is a significant predictor of poor driving performance and fitness to drive [25, 75, 82] | • UPDRS-motor scale should be part of the clinical evaluation in PD patients who come for fitness to drive assessment. | ||
• Poor rapid pace walk test correlated with poor driving performance [75, 88] | • RPW test may be considered as an off-road test in PD patients who come for fitness to drive evaluation. • More studies are needed to confirm its clinical validity. | |||
• Poor Webster’s scale correlated with poor driving performance [4] | • Webster’s scale should be part of the clinical evaluation in PD patients who come for fitness to drive assessment. | |||
Disease duration and/or LEDs [13, 14, 19, 20, 23, 65–67, 69, 73, 79, 81, 82, 86, 87, 89, 91] | • Disease duration and/or LEDs did not correlate with driving performance. | • Disease duration and medication review should form part of basic clinical evaluation in PD patients at every visit. | ||
Cognitive assessment | MMSE [3, 13, 14, 20, 21, 25, 37, 65, 66, 69–73, 75, 77–79, 82, 85–88] | • Poor MMSE score correlated with higher number of collisions [37] • Poor MMSE scores correlated with poor driving performance. [86, 88] | • MMSE should be part of the clinical evaluation in PD patients who come for fitness to drive assessment. | |
Trial A&B making test [13, 20, 21, 67–69, 72–75, 77, 78, 80, 82–84, 86, 87] | • Poor performance on Trail A&B making test correlated with poor driving performance and more driving errors [13, 67, 69, 75, 80, 83, 86] | • Neurocognitive tests should be considered in PD patients with cognitive complaints who come for fitness to drive assessment. | ||
• Poor performance on complex figure test correlated with poor driving performance. [13, 83, 84] | • Neurocognitive tests should be considered in PD patients with cognitive complaints who come for fitness to drive assessment. | |||
• Poor performance on block design tests correlated with poor driving performance [84, 86] | • Neurocognitive tests should be considered in PD patients with cognitive complaints who come for fitness to drive assessment. | |||
• Poor performance on Dot cancellation test correlated with decreased driving ability [74, 76] | • Neurocognitive tests should be considered in PD patients with cognitive complaints who come for fitness to drive assessment. | |||
Visual assessment | • Decreased UFOV score correlated with poor driving performance and higher collision risk [13, 25, 75, 80, 82, 84] | • Visual assessment with UFOV may be considered in PD patients who come for fitness to drive assessment. | ||
• Low-contrast visibility conditions imposed significant hazard for PD drivers. | • More studies are needed to confirm the validity of this test. | |||
• Poor visual acuity limits driving ability in PD patients. | • Visual acuity should be performed in PD patients who come for fitness to drive assessment. | |||
Driving simulators | Driving simulators (16 papers) | • PD drivers committed more driving errors than controls [4, 37, 63], • Greater PD disease severity determined with UPDRS or HY scale are correlated with poor driving performance [4] • Poor performance on cognitive test especially with executive testing and visual attention correlated with more driving errors [20, 37] • Driver assistance improved the driving performance in PD patients [69, 72] | • Physicians should consult local authorities on PD patients who may be unfit to drive for further evaluation. | |
4. Driving skill test | On-road tests (24 papers) | • PD drivers performed worse on on-road tests when compared to controls [3] • Greater PD disease severity determined with UPDRS or H&Y scale correlated with poor driving performance [3, 82, 89] • Poor performance on cognitive and/or visual tests affect driving ability in PD patients [25, 82] | • Physicians should consult local authorities on PD patients who may be unfit to drive for further evaluation. | |
Naturalistic driving (3 papers) | • PD drivers committed more errors, as shown by slow brake response time and slow reaction time [23] | • Physicians should consult local authorities on PD patients who may be unfit to drive for further evaluation. |